02/29/04 FILING

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

March 15, 2004

Accession Number

0001102598-04-000103

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →